Investor
Matt Sutherland
Individual investor
Key details
- Profile type
- Individual investor
- Geography
- Unknown / Other, Canada
- Stage
- 1. Idea or Patent, 2. Prototype, 3. Early Revenue, 4. Scaling
- Sector
- pharma, transcriptomics, drug, protein, IVD, biotech, life-science, biopharma, life sciences tools, medicines, proteomics, therapeutics, genomics, psychedelics, therapeutic, mRNA, biomarkers, pharmaceuticals, cell therapy, metabolomics, bio, CBD, in vitro diagnostics, CGT, cannabis, drugs, gene therapy, life science, psychedelic, lifesciences, metabolites, lifescience, life sciences
- Invests in
- ["Canada","USA","China","Hong Kong","Japan","Austria","Belgium","Croatia","Denmark","Finland","Germany","Ireland","Italy","Luxembourg","Netherlands","Norway","Poland","Portugal","Romania","Russia","Slovakia","Slovenia","Spain","Sweden","UK"]
- Investment size
- $50k to $1M
- Founder groups
- Not publicly stated
Official source
TorontoStarts does not endorse or rank this record. Confirm current details with the official source.